Otto Erik - 10 Feb 2026 SCHEDULE 13G/A Report for Chemomab Therapeutics Ltd. American Depository Shares, each of which represent twenty ordinary shares, no par value (GLTO)

Filing Manager
Otto Erik
Reporting Manager
Otto Erik
Security
Chemomab Therapeutics Ltd. American Depository Shares, each of which represent twenty ordinary shares, no par value
Symbol
GLTO
Shares outstanding
6,111,111 shares
Disclosed Ownership
385,000 shares
Ownership
6.3%
Form type
SCHEDULE 13G/A
Filing time
10 Feb 2026, 16:43:27 UTC
Date of event
10 Feb 2026
Previous filing
11 Aug 2025
SEC
View on sec.gov

Quoteable Key Fact

"Otto Erik disclosed 6.3% ownership in Chemomab Therapeutics Ltd. American Depository Shares, each of which represent twenty ordinary shares, no par value (GLTO) on 10 Feb 2026."

Quick Takeaways

  • Otto Erik filed SCHEDULE 13G/A for Chemomab Therapeutics Ltd. American Depository Shares, each of which represent twenty ordinary shares, no par value (GLTO).
  • Disclosed ownership: 6.3%.
  • Date of event: 10 Feb 2026.

What Changed

  • Previous schedule filing date: 11 Aug 2025.
  • Current filing was accepted on 10 Feb 2026, 16:43.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Otto Erik 6.3% 385,000 385,000 Erik Otto Individual